A cis-acting element in the promoter of human ether à go-go 1 potassium channel gene mediates repression by calcitriol in human cervical cancer cells

Biochemistry and Cell Biology

Volumn 93, Issue 1, 2015, Pages 94-101

  Cazares Ordonez V ^a,b   Gonzalez Duarte R J ^a,b   Diaz L ^a   Ishizawa, M ^c   Uno, S ^c   Ortiz V ^a   Ordonez Sanchez M L ^a   Makishima, M ^c   Larrea, F ^a   Avila, E ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

1 25 dihydroxyvitamin D3; Cervical cancer; HEAG K+ channel; VDIR; WSTF

Indexed keywords

CANCER CELLS; CYTOLOGY; DISEASES; ETHERS; POTASSIUM; TRANSCRIPTION; VITAMINS;

1 25-DIHYDROXYVITAMIN D3; CANCER CELLS; CERVICAL CANCERS; HEAG K+ CHANNEL; K+ CHANNELS; POTASSIUM CHANNELS; VDIR; VITAMIN D RECEPTOR; VITAMIN-D; WSTF;

TRANSCRIPTION FACTORS;

CALCITRIOL; CIS ACTING ELEMENT; POTASSIUM CHANNEL; RETINOID X RECEPTOR; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; KCNH1 PROTEIN, HUMAN; POTASSIUM CHANNEL HERG; TRANSCRIPTION FACTOR;

ARTICLE; CANCER CELL; CELL CYCLE PROGRESSION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA PROTEIN COMPLEX; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOLOCALIZATION; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; TRANSIENT TRANSFECTION; UTERINE CERVIX CANCER; VITAMIN D RESPONSIVE ELEMENT; DOWN REGULATION; GENETICS; METABOLISM; REGULATORY SEQUENCE; TUMOR CELL LINE; UTERINE CERVIX TUMOR;

CALCITRIOL; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; DOWN-REGULATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ETHER-A-GO-GO POTASSIUM CHANNELS; FEMALE; HUMANS; RECEPTORS, CALCITRIOL; REGULATORY SEQUENCES, NUCLEIC ACID; TRANSCRIPTION FACTORS; UTERINE CERVICAL NEOPLASMS; VITAMIN D RESPONSE ELEMENT;

EID: 84921949449     PISSN: 08298211     EISSN: 12086002     Source Type: Journal    
DOI: 10.1139/bcb-2014-0073     Document Type: Article

References (24)

1. Adams, C., and Fried, M.G. 2007. Analysis of protein-DNA equilibria by native gel electrophoresis. In Protein interactions: Biophysical approaches for the study of complex reversible systems. Edited by P. Schuck. Academic Press, New York. pp. 417-446.
2. Avila E. Garcia-Becerra R. Rodriguez-Rasgado J.A. Diaz L. Ordaz-Rosado D. Zugel U. et al 2010. Calcitriol down-regulates human ether a go-go 1 potassium channel expression in cervical cancer cells. Anticancer Res. 30 (7): 2667-2672. 20682996.
3. Barnett C. Krebs J.E. 2011. WSTF does it all: a multifunctional protein in transcription, repair, and replication. Biochem. Cell Biol. 89 (1): 12-23. 10.1139/O10-114. 21326359.
4. Carlberg C. Campbell M.J. 2013. Vitamin D receptor signaling mechanisms: integrated actions of a well-defined transcription factor. Steroids, 78 (2): 127-136. 10.1016/j.steroids.2012.10.019. 23178257.
5. Cartharius K. Frech K. Grote K. Klocke B. Haltmeier M. Klingenhoff A. et al 2005. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics, 21 (13): 2933-2942. 10.1093/bioinformatics/bti473. 15860560.
6. Diaz L. Ceja-Ochoa I. Restrepo-Angulo I. Larrea F. Avila-Chavez E. Garcia-Becerra R. et al 2009. Estrogens and human papilloma virus oncogenes regulate human ether-a-go-go-1 potassium channel expression. Cancer Res. 69 (8): 3300-3307. 10.1158/0008-5472.CAN-08-2036. 19351862.
7. Downie B.R. Sanchez A. Knotgen H. Contreras-Jurado C. Gymnopoulos M. Weber C. et al 2008. Eag1 expression interferes with hypoxia homeostasis and induces angiogenesis in tumors. J. Biol. Chem. 283 (52): 36234-36240. 10.1074/jbc.M801830200. 18927085.
8. Endo-Umeda K. Uno S. Fujimori K. Naito Y. Saito K. Yamagishi K. et al 2012. Differential expression and function of alternative splicing variants of human liver X receptor alpha. Mol. Pharmacol. 81 (6): 800-810. 10.1124/mol.111.077206. 22399489.
9. Farias L.M. Ocana D.B. Diaz L. Larrea F. Avila-Chavez E. Cadena A. et al 2004. Ether a go-go potassium channels as human cervical cancer markers. Cancer Res. 64 (19): 6996-7001. 10.1158/0008-5472.CAN-04-1204. 15466192.
10. Friedrich M. Rafi L. Mitschele T. Tilgen W. Schmidt W. Reichrath J. 2003. Analysis of the vitamin D system in cervical carcinomas, breast cancer and ovarian cancer. Recent results in cancer research. Recent Results Cancer Res. 164: 239-246. 10.1007/978-3-642-55580-0-17. 12899526.
11. Garcia-Becerra R. Diaz L. Camacho J. Barrera D. Ordaz-Rosado D. Morales A. et al 2010. Calcitriol inhibits Ether-a go-go potassium channel expression and cell proliferation in human breast cancer cells. Exp. Cell Res. 316 (3): 433-442. 10.1016/j.yexcr.2009.11.008. 19932096.
12. Garcia-Quiroz J. Garcia-Becerra R. Barrera D. Santos N. Avila E. Ordaz-Rosado D. et al 2012. Astemizole synergizes calcitriol antiproliferative activity by inhibiting CYP24A1 and upregulating VDR: a novel approach for breast cancer therapy. PLoS One, 7 (9): e45063. 10.1371/journal.pone.0045063. 22984610.
13. Kato S. Kim M.S. Yamaoka K. Fujiki R. 2007. Mechanisms of transcriptional repression by 1,25(OH)2 vitamin D. Curr. Opinion Nephrol. Hypertens. 16 (4): 297-304. 10.1097/MNH.0b013e3281c55f16. 17565270.
14. Kim M.S. Fujiki R. Murayama A. Kitagawa H. Yamaoka K. Yamamoto Y. et al 2007. 1Alpha,25(OH)2D3-induced transrepression by vitamin D receptor through E-box-type elements in the human parathyroid hormone gene promoter. Mol. Endocrinol. 21 (2): 334-342. 10.1210/me.2006-0231. 17095575.
15. Lin H. Li Z. Chen C. Luo X. Xiao J. Dong D. et al 2011. Transcriptional and post-transcriptional mechanisms for oncogenic overexpression of ether a go-go K+ channel. PLoS One, 6 (5): e20362. 10.1371/journal.pone.0020362. 21655246.
16. Lundqvist J. Wikvall K. Norlin M. 2012. Vitamin D-mediated regulation of CYP21A2 transcription-a novel mechanism for vitamin D action. Biochim. Biophys. Acta, 1820 (10): 1553-1559. 10.1016/j.bbagen.2012.04.017. 22561756.
17. Lundqvist J. Hansen S.K. Lykkesfeldt A.E. 2013. Vitamin D analog EB1089 inhibits aromatase expression by dissociation of comodulator WSTF from the CYP19A1 promoter-a new regulatory pathway for aromatase. Biochim. Biophys. Acta, 1833 (1): 40-47. 10.1016/j.bbamcr.2012.10.012. 23085504.
18. Matsunawa M. Akagi D. Uno S. Endo-Umeda K. Yamada S. Ikeda K. Makishima M. 2012. Vitamin D receptor activation enhances benzo[a]pyrene metabolism via CYP1A1 expression in macrophages. Drug Metab. Dispos. 40 (11): 2059-2066. 10.1124/dmd.112.046839. 22837390.
19. Murayama A. Kim M.S. Yanagisawa J. Takeyama K. Kato S. 2004. Transrepression by a liganded nuclear receptor via a bHLH activator through co-regulator switching. EMBO J. 23 (7): 1598-1608. 10.1038/sj.emboj.7600157. 15934135.
20. Ortiz C.S. Montante-Montes D. Saqui-Salces M. Hinojosa L.M. Gamboa-Dominguez A. Hernandez-Gallegos E. et al 2011. Eag1 potassium channels as markers of cervical dysplasia. Oncol. Rep. 26 (6): 1377-1383. 10.3892/or.2011.1441. 21887469.
21. Pardo L.A. del Camino D. Sanchez A. Alves F. Bruggemann A. Beckh S. Stuhmer W. 1999. Oncogenic potential of EAG K(+) channels. EMBO J. 18 (20): 5540-5547. 10.1093/emboj/18.20.5540. 10523298.
22. Pike J.W. 2011. Genome-wide principles of gene regulation by the vitamin D receptor and its activating ligand. Mol. Cell. Endocrinol. 347 (1-2): 3-10. 10.1016/j.mce.2011.05.012. 21664239.
23. Pike J.W. Meyer M.B. 2014. Fundamentals of vitamin D hormone-regulated gene expression. J. Steroid Biochem. Mol. Biol. 144 (Part A): 5-11. 10.1016/j.jsbmb.2013.11.004. 24239506.
24. Urrego D. Tomczak A.P. Zahed F. Stuhmer W. Pardo L.A. 2014. Potassium channels in cell cycle and cell proliferation. Philos. Trans. R. Soc., B, 369 (1638): 20130094. 10.1098/rstb.2013.0094. 24493742.